Pioglitazone attenuates allergic inflammation and induces production of regulatory T lymphocytes

American Journal of Rhinology and Allergy

Volumn 24, Issue 6, 2010, Pages 454-458

  Wang, Weihua ^a   Zhu, Zhenghua ^a   Zhu, Bingwei ^a   Ma, Zhaoxin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; PIOGLITAZONE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIALLERGIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; EOSINOPHIL; FEMALE; GENE EXPRESSION; MOUSE; NASAL LAVAGE; NASAL PRURITUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REGULATORY T LYMPHOCYTE; SENSITIZATION; SNEEZING; UPPER RESPIRATORY TRACT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; PPAR GAMMA; RHINITIS, ALLERGIC, PERENNIAL; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; THIAZOLIDINEDIONES;

EID: 78649957537     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3522     Document Type: Article

References (39)

1. Okano M, Azuma M, Yoshino T, et al. Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am J Respir Crit Care Med 164:1501-1507, 2001. (Pubitemid 33124034)
2. Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in china. Int Arch Allergy Immunol 149:47-57, 2009.
3. Brun RP, and Spiegelman BM. PPAR gamma and the molecular control of adipogenesis. J Endocrinol 155:217-218, 1997.
4. Chinetti G, Fruchart JC, and Staels B. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505, 2000.
5. Kota BP, Huang TH, and Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 51:85-94, 2005.
6. Clark RB. The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400, 2002.
7. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, et al. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 164:1364-1371, 2000. (Pubitemid 30067250)
8. Delerive P, Fruchart JC, and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169:453-459, 2001. (Pubitemid 32536978)
9. Natarajan C, and Bright JJ. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun 3:59-70, 2002.
10. Daynes RA, and Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759, 2002.
11. Ray DM, Akbiyik F, Bernstein SH, and Phipps RP. CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism. J Immunol 174:4060-4069, 2005. (Pubitemid 40395982)
12. Woerly G, Honda K, Loyens M, et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 198:411-421, 2003. (Pubitemid 36976052)
13. Mueller C, Weaver V, Vanden HJ, et al. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys 418:186-196, 2003. (Pubitemid 37159385)
14. Kang HJ, Cinn YG, Hwang SJ, et al. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg 132:1196-1200, 2006. (Pubitemid 44800132)
15. Benayoun L, Letuve S, Druilhe A, et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: Relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 164:1487-1494, 2001. (Pubitemid 33124032)
16. Honda K, Marquillies P, Capron M, and Dombrowicz D. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol 113:882-888, 2004. (Pubitemid 38608597)
17. August A, Mueller C, Weaver V, et al. Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma. J Nutr 136:695-699, 2006.
18. Bluestone JA. Regulatory T-cell therapy: Is it ready for the clinic? Nat Rev Immunol 5:343-349, 2005.
19. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363:608-615, 2004. (Pubitemid 38264178)
20. Doganci A, Eigenbrod T, Krug N, et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 115:313-325, 2005.
21. Prescott SL, and Dunstan JA. Immune dysregulation in allergic respiratory disease: The role of T regulatory cells. Pulm Pharmacol Ther 18:217-228, 2005. (Pubitemid 40222118)
22. Tang Q, and Bluestone JA. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 9:239-244, 2008. (Pubitemid 351267321)
23. Housley WJ, O'Conor CA, Nichols F, et al. PPARgamma regulates retinoic acid-mediated DC induction of Tregs. J Leukoc Biol 86:293-301, 2009.
24. Blair C, Nelson M, Thompson K, et al. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol 108:424-429, 2001. (Pubitemid 32881065)
25. Klotz L, Dani I, Edenhofer F, et al. Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. J Immunol 178:2122-2131, 2007. (Pubitemid 46233409)
26. Akahori T, Sho M, Hamada K, et al. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol 47:784-792, 2007. (Pubitemid 350051123)
27. Srinivasan K, Patole PS, Kaul CL, and Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26:327-333, 2004. (Pubitemid 38954807)
28. Kubota N, Terauchi Y, Kubota T, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281:8748-8755, 2006.
29. Trifilieff A, Bench A, Hanley M, et al. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: In vitro evidence for an NF-kappaB-independent effect. Br J Pharmacol 139:163-171, 2003.
30. Hamelmann E, and Gelfand EW. IL-5-induced airway eosinophilia - The key to asthma? Immunol Rev 179:182-191, 2001.
31. Lee KS, Park SJ, Hwang PH, et al. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J 19:1033-1035, 2005.
32. Padilla J, Leung E, and Phipps RP. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol 103:22-33, 2002. (Pubitemid 34478417)
33. Miyazaki Y, Tachibana H, and Yamada K. Inhibitory effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of IgE heavy chain germline transcripts in the human B cell line DND39. Biochem Biophys Res Commun 295:547-552, 2002. (Pubitemid 34785870)
34. Han JL, Ding RY, Zhao L, et al. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis. J Int Med Res 36:830-836, 2008.
35. Won HY, Min HJ, Ahn JH, et al. Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation. Biochem Pharmacol 79:888-896, 2010.
36. Wohlfert EA, Nichols FC, Nevius E, and Clark RB. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: Enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol 178:4129-4135, 2007. (Pubitemid 46492362)
37. Yamamoto K, Kawamura I, Tominaga T, et al. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells. Clin Exp Immunol 142:268-274, 2005. (Pubitemid 41565242)
38. Xu G, Mou Z, Jiang H, et al. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope 117:876-880, 2007. (Pubitemid 46699362)
39. Cosmi L, Liotta F, Angeli R, et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103:3117-3121, 2004.